VTGN - VistaGen Therapeutics GAAP EPS of -$0.22 beats by $0.08 revenue of $0.41M misses by $0.13M
2024-02-13 16:33:22 ET
More on VistaGen Therapeutics
- VistaGen: Positive Data Leads To Catalysts In 2024 And Beyond
- Vistagen shares move up after Jefferies upgrade
- Seeking Alpha’s Quant Rating on VistaGen Therapeutics
- Historical earnings data for VistaGen Therapeutics
- Financial information for VistaGen Therapeutics